Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7364
pubmed:dateCreated
2011-9-16
pubmed:abstractText
Infections by the Ebola and Marburg filoviruses cause a rapidly fatal haemorrhagic fever in humans for which no approved antivirals are available. Filovirus entry is mediated by the viral spike glycoprotein (GP), which attaches viral particles to the cell surface, delivers them to endosomes and catalyses fusion between viral and endosomal membranes. Additional host factors in the endosomal compartment are probably required for viral membrane fusion; however, despite considerable efforts, these critical host factors have defied molecular identification. Here we describe a genome-wide haploid genetic screen in human cells to identify host factors required for Ebola virus entry. Our screen uncovered 67 mutations disrupting all six members of the homotypic fusion and vacuole protein-sorting (HOPS) multisubunit tethering complex, which is involved in the fusion of endosomes to lysosomes, and 39 independent mutations that disrupt the endo/lysosomal cholesterol transporter protein Niemann-Pick C1 (NPC1). Cells defective for the HOPS complex or NPC1 function, including primary fibroblasts derived from human Niemann-Pick type C1 disease patients, are resistant to infection by Ebola virus and Marburg virus, but remain fully susceptible to a suite of unrelated viruses. We show that membrane fusion mediated by filovirus glycoproteins and viral escape from the vesicular compartment require the NPC1 protein, independent of its known function in cholesterol transport. Our findings uncover unique features of the entry pathway used by filoviruses and indicate potential antiviral strategies to combat these deadly agents.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1476-4687
pubmed:author
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
477
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
340-3
pubmed:dateRevised
2011-11-3
pubmed:meshHeading
pubmed-meshheading:21866103-Animals, pubmed-meshheading:21866103-Biological Transport, pubmed-meshheading:21866103-Carrier Proteins, pubmed-meshheading:21866103-Cell Line, pubmed-meshheading:21866103-Cholesterol, pubmed-meshheading:21866103-Ebolavirus, pubmed-meshheading:21866103-Endosomes, pubmed-meshheading:21866103-Fibroblasts, pubmed-meshheading:21866103-Genome, Human, pubmed-meshheading:21866103-Glycoproteins, pubmed-meshheading:21866103-Haploidy, pubmed-meshheading:21866103-Hemorrhagic Fever, Ebola, pubmed-meshheading:21866103-Host-Pathogen Interactions, pubmed-meshheading:21866103-Humans, pubmed-meshheading:21866103-Lysosomes, pubmed-meshheading:21866103-Marburg Virus Disease, pubmed-meshheading:21866103-Marburgvirus, pubmed-meshheading:21866103-Membrane Fusion, pubmed-meshheading:21866103-Membrane Glycoproteins, pubmed-meshheading:21866103-Multiprotein Complexes, pubmed-meshheading:21866103-Mutation, pubmed-meshheading:21866103-Niemann-Pick Diseases, pubmed-meshheading:21866103-Receptors, Virus, pubmed-meshheading:21866103-Viral Fusion Proteins, pubmed-meshheading:21866103-Virus Internalization
pubmed:year
2011
pubmed:articleTitle
Ebola virus entry requires the cholesterol transporter Niemann-Pick C1.
pubmed:affiliation
Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, Massachusetts 02142, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural